Key result
Risk Analysis Index outperforms mFI-5 for predicting 30-day mortality after occipitocervical fusion.
Why the study?
The predictive performance of the Risk Analysis Index and Modified 5-Item Frailty Index for adverse postoperative outcomes after occipitocervical fusion was unclear.
Does the Risk Analysis Index (RAI) outperform the Modified 5-Item Frailty Index (mFI-5) in predicting 30-day morbidity and mortality in patients undergoing occipitocervical fusion?
Cohort (n=1,637)
Yes
Does the Risk Analysis Index (RAI) outperform the Modified 5-Item Frailty Index (mFI-5) in predicting 30-day morbidity and mortality in patients undergoing occipitocervical fusion?
The Risk Analysis Index outperforms the Modified 5-Item Frailty Index in predicting 30-day mortality and major complications following occipitocervical fusion.
Answers are grounded in this paper and cite their sources.
RAI may aid mortality risk stratification in occipitocervical fusion; leaves open prospective validation before replacing mFI-5.
Study Design Retrospective Cohort Study. Objectives To evaluate the predictive performance of the Risk Analysis Index (RAI) and Modified 5-Item Frailty Index (mFI-5) in identifying risk for adverse postoperative outcomes in patients undergoing occipitocervical fusion (OCF). Methods The American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database was queried for patients who underwent OCF from 2015 to 2020. Frailty was measured using both the RAI and mFI-5. The primary outcome was 30-day mortality. Secondary outcomes included major complications, minor complications, unplanned readmission, extended length of stay (eLOS), and non-home discharge (NHD). Multivariable logistic regression was used to assess associations, while receiver operating characteristic (ROC) curve analysis evaluated model discrimination. Results A total of 1637 patients were included (median age 68 years; 51.4% male). Higher frailty scores on both RAI and mFI-5 were associated with increased odds of mortality, major complications, and NHD. However, the RAI demonstrated superior discrimination for predicting mortality (C-statistic: 0.79 [95% CI: 0.75-0.83]) compared to mFI-5 (0.57 [95% CI: 0.53-0.61], P < .001), as well as for major complications (RAI: 0.64 vs mFI-5: 0.57, P = .01) and NHD (RAI: 0.73 vs mFI-5: 0.65, P < .001). Conclusions The RAI outperformed the mFI-5 in predicting key adverse outcomes following OCF. Incorporating RAI into preoperative evaluation may improve frailty-based risk stratification and guide surgical decision-making in vulnerable patients.
No takes yet. Share an insight, caveat, or question.
Sbaih et al. (2025) conducted a cohort in Occipitocervical fusion (OCF) (n=1,637). Risk Analysis Index (RAI) vs. Modified 5-Item Frailty Index (mFI-5) was evaluated on 30-day mortality (C-statistic 0.79, 95% CI 0.75-0.83, p=<.001). The Risk Analysis Index demonstrated superior discrimination for predicting 30-day mortality after occipitocervical fusion compared to the mFI-5.
Synapse has enriched 10 related papers. Consider them for comparative context: